OguzO Capitalist
OguzO Capitalist
Selective contrarian investor | The writer of the Capitalist-Letters newsletter
15Follow
282Followers
0Topic
0Badge

Here are 10 Stocks that'll Benefit from Lower Rates

The Fed has just cut interest rates again and signaled another rate cut next year.Here are 10 stocks that'll benefit from lower rates: đŸ§”1. $Pagaya Technologies Ltd.(PGY)$ - Leading second-look lending network.- Expanding into auto loans and BNPL.- Markdowns are normalizing.Analysts expect 17% growth next year, but it's too low in my opinion. It can do way better in a lower-rate environment.It's an asymmetric opportunity at 15x earnings, given that estimates are likely too low.Image2. $Upstart Holdings, Inc.(UPST)$ - Leading AI-powered lending marketplace.- Originations grew 80% YoY, reaching $2.9 billion.- It's trading at 15x 2027 earnings despite strong growth.It got sold off after Q3 results because inve
Here are 10 Stocks that'll Benefit from Lower Rates

Trading Ideas: UNH, NVO& ASML

1. $ASML Holding NV(ASML)$ has 100% market share in EUVL machines.Down 60% from highs. $Novo-Nordisk A/S(NVO)$ controls 40% of global insulin and 54% of GLP-1 market.Down 67% from highs. $UnitedHealth(UNH)$ is the largest healthcare company in the world and dominates the US market.Down 63% from highs.Sometimes it’s easy.2.Everybody when NVO was at $150: “Give it to me at $100.”NVO at $48: “I am not buying because..”Everybody knows what’s the right thing to do, they just don’t have the stomach.Image3. $UnitedHealth(UNH)$ is now trading at 8 times operating cash flow
This is the largest healthcare company in the world, poised
Trading Ideas: UNH, NVO& ASML

Here is Why NVO is a 2x Opportunity Now

1/ $Novo-Nordisk A/S(NVO)$ was once a market darling, now everybody hates it.Yet, growth is still strong, the oral Wegovy is coming this quarter, and it has the strongest pipeline in weight-loss drugs.Here is why NVO is a 2x opportunity now: đŸ§”2/ Let's set the stage first: What does NVO do?NVO is the global leader in diabetes treatment with a 33% market share.This market has three main segments:- Oral Anti-Diabetes drugs- Insulin- GLP-1NVO holds the leadership position in all these markets.Image3/ It currently controls 42% of the global insulin market.This has traditionally been Novo Nordisk's biggest business.However, the balance is shifting.Last year, insulin made up only 18% of the shares, while GLP-1 products made up 50% of all sales.Image4/ NVO
Here is Why NVO is a 2x Opportunity Now

Trading Ideas: UNH& TMDX

Hello everyone! Today i want to share some trading ideas with you!1. $UnitedHealth(UNH)$ is now the 10th most held stock by superinvestors according to Dataroma.This will prove a generational buying opportunity.Healthcare now is financials in 2008. $UnitedHealth(UNH)$ $Elevance Health(ELV)$ $Oscar Health, Inc.(OSCR)$Image2.Chris Davis added 1 million shares of $UnitedHealth(UNH)$ last quarter at an average price of $311.Chris Davis isn’t your ordinary hedge fund manager, he is one of the best value investors of our time.When he does something, we pay attention.Image3.
Trading Ideas: UNH& TMDX

Here is Why UNH is an Asymmetric Opportunity Now

1/ $UnitedHealth(UNH)$ is one of my highest conviction stocks for the next 5 years.It is an easy 3x from the current levels.Here is why UNH is an asymmetric opportunity now: đŸ§”2/ $UnitedHealth(UNH)$ is dominating healthcare in the US.As a group, UnitedHealth owns:- Largest health insurer in the US- Largest care delivery network- Largest pharmacy benefit managerThese businesses are integrated under one roof, making it a vertically integrated giant.Image3/ Its vertical integration allows it to keep more money in the system compared to the competitors.Clients pay policy premiums to UnitedHealthcare.When they need health services, they primarily use Optum.UnitedHealthcare pays Optum, thus UNH group avoids premiu
Here is Why UNH is an Asymmetric Opportunity Now

Here is my AMD Investment Thesis!

1/ $Advanced Micro Devices(AMD)$ has just signed a $100 billion chip deal with OpenAI.This is just the beginning.It has a path to become a $1 trillion company as it's catching up with $NVIDIA(NVDA)$ in both hardware and software.Here is my AMD investment thesis: đŸ§”Lisa Su holding two semiconductor chips in her hands. She stands in front of a large AMD logo on a dark background.2/ AI infrastructure spending is accelerating.Most people still don't see what's coming.Jensen Huang thinks that annual AI-chip spending will reach $1 trillion by the end of this decade.This is a massive total addressable market for both AMD and NVDA.3/ NVDA has taken the lion's share of this market so far.This was because of two reas
Here is my AMD Investment Thesis!

UNH: High Potential to Buy!

1.Here is how I see the market right now:- The overall market is expensive.- Inflation may tick up soon due to tariffs, etc.- Commercial credit is weaker than consumer credit.This is a time to think more defensively than offensively.Healthcare is there for defensive positioning, trading at just 17× forward earnings versus 23× for the S&P.The largest healthcare providers are still down about 40% from their highs, and they are guiding for growth next year.Hedge funds are buying, members of Congress are buying, and even Buffett is buying.I think the sector deserves some attention now.Especially $UnitedHealth(UNH)$ .Line chart titled S and P 500 versus Health Care Forward P E dated October 10 2024, showing red line for S and P 500 forward P E and b
UNH: High Potential to Buy!

AMD: Sales will Skyrocket, the Stock will Follow

1. $Advanced Micro Devices(AMD)$ is selling off because data center sales went down two quarters in a row..It’s not a demand problem.AMD is behind $NVIDIA(NVDA)$ in time to market. When AMD catches up, NVDA launches the next-gen design.This is changing with MI400 series.When NVDA launches Rubin, MI400 will follow shortly after to compete effectively.It’s when we’ll see AMD meaningfully gain market share instead of feeding on breadcrumbs.Sales will skyrocket, the stock will follow.Image2. $Oscar Health, Inc.(OSCR)$ is so obvious at this point that it’s going vertical despite the earnings miss.It’s simple: Revenue grows 30% annually in the next 2 years and it achiev
AMD: Sales will Skyrocket, the Stock will Follow

Here is Why NVO is an Asymmetric Opportunity

1/ $Novo-Nordisk A/S(NVO)$ was once a market darling, now everybody hates it.It dominates the global insulin and weight-loss drugs markets. Even if it delivers a high single-digit annualized growth in the next 5 years, the stock will double.Here is why NVO is an asymmetric opportunity: đŸ§”2/ NVO was nearly trading at 3x of today's valuation in January.What changed?Nothing more than the sentiment.Let me explain:Image3/ NVO still dominates the global diabetes market.It currently controls over 34% of the global diabetes treatment market, up from 30% in 2021.Even if the growth in the weight-loss segment stops, this segment is large enough to support high-single-digit long-term growth.Image4/ What about the competition from
Here is Why NVO is an Asymmetric Opportunity

OSCR is Going at the Right Direction!

Hello everyone! Today i want to share some trading skills with you! $Oscar Health, Inc.(OSCR)$ earnings dropped, nothing unexpected.Revenue of $2.86B vs $2.92 Est. ❌EPS of -$0.89 vs -$0.88 Est. ❌Healthcare is going through a great reset.OSCR is going at the right direction.Revenue doubled YoY and it added 500,000 members.They mispredicted the activity rates and medical costs, so the loss ratio is off the roof, just like the whole healthcare sector.It won’t remain this way.The sector accurately predicted medical costs and activity rates before 2023, they’ll return to that for sure.If you can deploy capital with an illiquid mindset, healthcare now offers a great opportunity.OSCR, in particular, will surely be an at least 3-4x stock in the next coupl
OSCR is Going at the Right Direction!

HIMS, NBIS& OSCR: Potential Stocks to Buy

1. $Hims & Hers Health Inc.(HIMS)$ is rapidly evolving into an ecosystem business.Home-testing is the next step in this strategy:1) Home-testing will provide HIMS with comprehensive personal data.2) HIMS will tailor personalized solutions using the data.3) Personalization will lock-in customers, reducing contestable share of the market.Even though compounded medicine have no moat, other providers will struggle matching $HIMS data advantage at scale because of shrinking contestable market.This is how HIMS is turning a fragmented market into a concentrated one, reinforcing its leadership.Extremely bullish for HIMS.Short term target $60, buy zone below $35.2. $NEBIUS(NBIS)$ got a “Buy” rating from Goldma
HIMS, NBIS& OSCR: Potential Stocks to Buy

DLO: Here is Why it's a 5x Opportunity Now

$DLocal Limited(DLO)$ is one of the most asymmetric opportunities in the market now.Payment volume is growing insanely fast, it is rapidly expanding in emerging markets, and the take rate is finally increasing.Here is why it's a 5x opportunity now: đŸ§”1/ What does DLO do?It's actually an online payment gateway, similar to Stripe and Adyen.Where it differs is that it brings together local payment methods in one API.This provides it with an advantage where payment methods are fragmented, i.e, in emerging markets.Image2/ It's rapidly growing its presence in emerging markets.It's the leading payment gateway API in Latin America, and it's growing fast in Africa and Asia.Currently, they are active in over 30 countries and support more than 600 payment meth
DLO: Here is Why it's a 5x Opportunity Now

Here is My AMZN Investment Thesis

$Amazon.com(AMZN)$ is the cheapest mega-cap stock now.The stock has been flat since last December despite accelerating AWS growth and expanding profit margin.I think it can easily double from here in the next 5 years.Here is my AMZN investment thesis: đŸ§”1/ AMZN has a strong market position in three fast-growing markets:- Online shopping- Cloud computing - Digital advertisingIt is the market leader in cloud and e-commerce and the third largest digital advertiser in the world.All these segments are still growing fast.Image2/ Let's start with cloud computing, Amazon's cash cow.AMZN is the leader in the global cloud business with 29% market share, while MSFT is at 22% and $GOOG is at 13%.It looks like Amazon's market share is trending down here, but it
Here is My AMZN Investment Thesis

AI Industry Chain

1. $Amazon.com(AMZN)$ is the cheapest mega-cap stock now.It’s only up 30% since 2020 despite doubling the revenue.It has grown into its overvaluation.Now it’s cheap again, trading at just 19 times operating cash flow.The stock didn’t move because the market believes that AWS is losing the AI infrastructure race as its growth lagged other hyperscalers.However, AWS will reaccelerate as Anthropic’s gigawatt scale Trainium clusters start operation this quarter.Once AWS accelerates, the market will reprice it. Long $Amazon.com(AMZN)$ .Dark-themed financial chart from TrendSpider displaying Amazon AMZN weekly stock performance from 2021 to 2025 with candlestick patterns in green and red, price scale on right fr
AI Industry Chain

Here is My Updated SOFI Investment Thesis

1/ $SoFi Technologies Inc.(SOFI)$ train is taking off.Growth is accelerating, the business is becoming increasingly capital-light, and it's rapidly entering new markets.Here is my updated SOFI investment thesis: đŸ§”2/ Member growth is accelerating.SOFI added a mind-blowing 1.8 million members since Q4 2024.This is the fastest rate at which the company has grown its membership in any two consecutive quarters.This will result in accelerated product growth in the next few quarters.Image3/ Lending is accelerating too.This is SOFI's biggest business, and it's accelerating.In the last quarter, originations reached a record $799 million.This can further accelerate as the Fed cuts rates and SOFI grows its deposit base.Image4/ Technology business is back to
Here is My Updated SOFI Investment Thesis

Buying This Growth Stock With 3x Potential!

Never invest in the present, always invest in the future—says Stanley Druckenmiller.This one sentence perhaps best summarizes the nature of investment returns.Everybody likes profitable businesses that are still growing fast. Yet, when it’s obvious that this is the case, the price is generally in the sky already. Most future growth is priced in, and there is not much money left in it to be made.Conversely, those who invest before it’s obvious make insane amounts of money.For most companies, you have plenty of opportunity to invest before the inflection point. If you look right, you can see it coming and invest before the masses.First, unit economics drastically improve; then operating cash flow shifts positive and GAAP profitability follows— when it happens, the stock price skyrockets.Resu
Buying This Growth Stock With 3x Potential!

Here is My SLNH Investment Thesis

1/ $Soluna Holdings, Inc.(SLNH)$ is the cheapest data center stock in the market.It has nearly 1GW capacity under development with 2GW of pipeline.If they can execute, the stock can easily make 6x from here.Here is my SLNH investment thesis: đŸ§”Mountainous landscape with layered ridges under a hazy sky features several white wind turbines on green hills in the foreground and a winding road leading into the distance. Prominent overlaid text reads SOLUNA in large blue and orange letters with a triangular symbol.2/ SLNH builds data centers near renewable power plants to benefit from excess generation.One-third of the power generated from renewables is wasted due to grid congestion and a lack of storage.Soluna uses excess generation to power data center
Here is My SLNH Investment Thesis

AMD Excels All!

This is the $Advanced Micro Devices(AMD)$ investment thesis.The bulk of the costs to run AI models comes from inference and training. $NVIDIA(NVDA)$ dominates training due to its first-mover advantage, NVLink, and CUDA.Currently, most models run inference tasks on the same chips used for training, which is why the costs are so similar.But this is about to change.As the gains from pre-training begin to flatline, training workloads will decline while inference demand will skyrocket.Inference requires as much memory as possible within a single server. $Advanced Micro Devices(AMD)$ excels here.Its expertise in chiplet design allows it to connect multiple memory dies to
AMD Excels All!

Here is Why FLNC is an Asymmetric Opportunity

1/ $Fluence Energy, Inc.(FLNC)$ is the leading utility-scale battery provider with 5x potential.Power demand is exploding due to rapid data center buildout.Most of the new capacity should come from renewables, where storage is critical.Here is why FLNC is an asymmetric opportunity: đŸ§”2/ First, some background.AI is driving rapid data center buildout across the world.Bloomberg expects that data center power demand will quadruple in the next 10 years.Where will this supply come from?Image3/ Most of the supply will come from renewables.Fossil fuels will be largely depleted in the next 50 years, so renewables and nuclear are the only options.Bloomberg expects 70% of power will come from renewables in 2050.However, renewables come with challenges..Image
Here is Why FLNC is an Asymmetric Opportunity

Why aren’t you Buying UNH?

1.Hello everyone! Today i want to share some trading ideas with you!Warren BuffettMichael BurryGeorge SorosDavid TepperChris DavisWhat do they have in common?They bought large amounts of $UnitedHealth(UNH)$ last quarter.Meanwhile the stock is still trading lower than Buffett’s average price of $311 per share.Why aren’t you buying UNH?Image2. $UnitedHealth(UNH)$ here is literally $metain 2022.- 11% annual revenue growth.- $25 billion free cash flow.- Trading at 9x FCF.Healthcare is going nowhere, and AI will make the firms just more efficient, helping them expand margins.Why aren't you still buying it?ImageFor whom haven't open CBA can know more from below:🏩 Open a CBA today and enjoy privileges of up to SGD
Why aren’t you Buying UNH?

Go to Tiger App to see more news